ReviewJournal of clinical medicine2024

Bevacizumab for Vestibular Schwannomas in Neurofibromatosis Type 2: A Systematic Review of Tumor Control and Hearing Preservation.

Melina Screnci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.